Holen Sie sich die Stockscreener-App
288.42
1.92%
5.44
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$282.98
Offen:
$284.3
24-Stunden-Volumen:
1.28M
Relative Volume:
0.74
Marktkapitalisierung:
$56.12B
Einnahmen:
$328.68B
Nettoeinkommen (Verlust:
$2.55B
KGV:
22.13
EPS:
13.0349
Netto-Cashflow:
$1.56B
1W Leistung:
+1.39%
1M Leistung:
+8.97%
6M Leistung:
-14.61%
1J Leistung:
-2.34%
1-Tages-Spanne:
$280.96
$288.60
1-Wochen-Bereich:
$278.51
$293.78
52-Wochen-Spanne:
$244.82
$377.54
Cencora Inc Stock (COR) Company Profile
Firmenname
Cencora Inc
Sektor
Branche
Telefon
610-727-7000
Adresse
1 WEST FIRST AVENUE, CONSHOHOCKEN
Compare COR vs MCK, CAH, HSIC, AHG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
288.42 | 55.06B | 328.68B | 2.55B | 1.56B | 13.03 |
MCK
Mckesson Corp
|
768.06 | 88.46B | 403.43B | 5.10B | 5.41B | 38.47 |
CAH
Cardinal Health Inc
|
237.72 | 55.64B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
84.52 | 9.51B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
1.51 | 1.28B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-29 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2026-01-22 | Hochstufung | Jefferies | Hold → Buy |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-06-03 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-12-04 | Fortgesetzt | Mizuho | Outperform |
| 2024-09-18 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-03-31 | Eingeleitet | Citigroup | Buy |
| 2023-01-31 | Fortgesetzt | Evercore ISI | Outperform |
| 2022-10-11 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-07-11 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-06-07 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-05-26 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-04-12 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-12 | Fortgesetzt | Evercore ISI | In-line |
| 2021-02-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-02-02 | Hochstufung | Cowen | Market Perform → Outperform |
| 2021-01-06 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2021-01-06 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-10 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2020-12-03 | Eingeleitet | Mizuho | Neutral |
| 2020-08-06 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-07-15 | Eingeleitet | Barclays | Underweight |
| 2020-06-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-23 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-04-16 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-04-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-04-01 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-03-17 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-02-11 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2020-02-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-07-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-11 | Eingeleitet | Guggenheim | Buy |
| 2019-04-10 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2019-04-10 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-02-11 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2018-12-10 | Herabstufung | Jefferies | Buy → Hold |
| 2018-10-26 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-09-20 | Eingeleitet | Berenberg | Buy |
| 2018-07-17 | Fortgesetzt | Stifel | Hold |
| 2018-04-09 | Eingeleitet | MoffettNathanson | Buy |
| 2018-03-12 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-12 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2017-09-25 | Eingeleitet | JP Morgan | Neutral |
| 2017-09-22 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Cencora Inc Aktie (COR) Neueste Nachrichten
Cencora announces Q3 FY26 earnings release date - scanx.trade
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Cencora Announces Date and Time for Third Quarter Fiscal 2026 Earnings Release - FinancialContent
Cencora Inc. focuses on pharmaceutical distribution and healthcare services - AD HOC NEWS
Cencora CubixxCT from Cencora Inc.cold-chain automation for hospital pharmacies - AD HOC NEWS
Form 4 Cencora Inc For: 30 June By Investing.com - Investing.com Canada
Cencora (COR) CFO receives 21,304 restricted stock units vesting through 2029 - Stock Titan
Cencora (COR) CFO files Form 3 showing small direct and trust holdings - Stock Titan
Cencora Pick of the Week at Smart Insider Following Chairman's Share Purchase - marketscreener.com
Cencora reports steady business model, shares anchored in US healthcare distribution - AD HOC NEWS
Cencora, Inc. (COR) Investigation: Bronstein, Gewirtz & Grossman - The National Law Review
The Velocity patient support solution from Cencora Inc.integrated care for specialty therapies - AD HOC NEWS
Cencora Inc. stock underperforms Monday when compared to competitors - MarketWatch
Cencora operations and strategy, shares reflect ongoing integration of COR acquisition - AD HOC NEWS
Cencora (COR) Stock After Recent Pullback And DCF Valuation Gap - Yahoo Finance
Nucleus inventory solution from Cencora Inc.modular cabinets and tighter control for specialty pr - AD HOC NEWS
Cencora (COR) Launches Nucleus Pilot As Verizon Executive Joins As CHRO - Yahoo Finance
Cencora revises 2026 outlook, shares underpinned by buyback and analyst support - Ad-hoc-news.de
Knights of Columbus Large Cap Value Fund's Cencora Inc(COR) Holding History - GuruFocus
Cencora, S&P 500 peer under pressure, shares lag broader healthcare distributors - Ad-hoc-news.de
3 Big Reasons to Love Cencora (COR) - Yahoo Finance
Cencora (COR) Stock After Healthcare Supply Chain Reassessment Is The Market Overreacting - simplywall.st
Price to sales forward of Cencora, Inc. – NYSE:COR - TradingView
Cencora adjusts amid healthcare shifts, shares trade steadily on NYSE - Ad-hoc-news.de
Enterprise value to revenue forward of Cencora, Inc. – LS:766149 - TradingView
Enterprise value to EBIT forward of Cencora, Inc. – NYSE:COR - TradingView
Cencora, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh - TradingView
AQR Trend Total Return Fund's Cencora Inc(COR) Holding History - GuruFocus
Cencora, Inc. Actuals & Estimates (NYSE:COR) - TradingView
Enterprise value to EBIT forward of Cencora, Inc. – LS:766149 - TradingView
COR Forecast — Price Target — Prediction for 2027 - TradingView
Cencora analyst targets imply upside, shares in S&P 500 healthcare focus - Ad-hoc-news.de
Cencora raises earnings outlook on share repurchases - MSN
Cencora (COR) Q2 2026 Earnings Call Transcript - Fortune
Price to earnings forward of Cencora, Inc. – NYSE:COR - TradingView
Price to earnings forward of Cencora, Inc. – LS:766149 - TradingView
Centene Corp updates home health strategy, shares tracked against managed care peers - Ad-hoc-news.de
Cencora (COR) Launches Nucleus Pilot And Names A New HR Chief - Sahm
Cencora Inc (COR) Institutional Confidence - TradingKey
Price to book forward of Cencora, Inc. – LS:766149 - TradingView
Insider Buying: Lauren Tyler Acquires Shares of Cencora Inc (COR) - GuruFocus
Are Wall Street analysts bullish on Cencora stock? - MSN
Cencora (COR) director Lauren M. Tyler buys 550 shares in open market - Stock Titan
Argus Adjusts Price Target on Cencora to $340 From $4000, Maintains Buy Rating - Moomoo
BofA Adjusts Price Target on Cencora to $285 From $280 - marketscreener.com
Cencora Inc (COR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
A Look at Cencora Inc (COR) After 3.6% Gain -- GF Value $291.84 vs Price $281.10 - GuruFocus
Cencora insider buying draws attention, shares trade higher on NYSE - Ad-hoc-news.de
Cencora Inc (COR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Insider Buying: Dermot Durcan Acquires Additional Shares of Cenc - GuruFocus
Jared Moskowitz from Florida’s 23rd District Trades in Cencora and Gilead Sciences Stocks By Investing.com - Investing.com Australia
Finanzdaten der Cencora Inc-Aktie (COR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):